trial · primary record
survodutide
Obesity
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 5530 |
| Primary completion | 2026-06-30 |
| Primary endpoint | Time to first occurrence of any of the adjudicated components of the composite endpoint consisting of: CV death, non-fatal stroke, non-fatal MI, ischaemia related coronary revascularisation, or HFE (to demonstrate non-inferiority) |
| Registry ID | NCT06077864 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:13.345Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06077864
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Survodutide · compound